693 BC MSP code: Dermatitis due to substances taken internally

693 is the BC MSP diagnostic code for “Dermatitis due to substances taken internally” in BC Medical Services Plan’s September 2026 release, in effect from Sep 11, 2026.

Official description

693

Dermatitis due to substances taken internally

BC MSP diagnostic codes (ICD-9) · British Columbia

More specific than 693

693 is a valid code on its own. When the note says more, one of these may fit better.

Notes for 693

BC Medical Services Plan’s list gives no includes, excludes or other notes for 693 or the headings above it.

Where 693 sits

  1. 1SectionDiseases of the skin and subcutaneous tissues
  2. 2SubsectionOther inflammatory conditions of skin and subcutaneous tissue (690 – 698.9)
  3. 3Valid code 693Dermatitis due to substances taken internally

Source and release

Data release
BC MSP · September 2026
Effective date
Sep 11, 2026

This page is built from the BC MSP catalog that Vero Codes reads when it suggests codes: BC Ministry of Health, Medical Services Plan’s September 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does BC MSP diagnostic code 693 mean?

693 is the BC MSP diagnostic code for “Dermatitis due to substances taken internally” in BC Medical Services Plan’s BC MSP September 2026 release.

Where is 693 in the BC MSP list?

693 is listed under Diseases of the skin and subcutaneous tissues, Other inflammatory conditions of skin and subcutaneous tissue (690 – 698.9).

What coding notes apply to 693?

BC Medical Services Plan’s list gives no includes, excludes or other notes for 693 or the headings above it.

Which BC MSP release does this page use?

It uses BC Medical Services Plan’s September 2026 release, in effect from Sep 11, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.